Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons

The Journal of Microbiology
Yee Ching NgMoon Jung Song

Abstract

Human noroviruses are the causative agents of non-bacterial gastroenteritis worldwide. The rapid onset and resolution of disease symptoms suggest that innate immune responses are critical for controlling norovirus infection; however, no effective antivirals are yet available. The present study was conducted to examine the antiviral activities of Schizonepeta tenuifolia Briquet extract (STE) against noroviruses. Treatment of human norovirus replicon-bearing HG23 cells with STE at 5 and 10 mg/ml concentrations resulted in the reduction in the viral RNA levels by 77.2% and 85.9%, respectively. STE had no cytotoxic effects on HG23 cells. Treatment of RAW 264.7 cells infected with murine norovirus 1 (MNV-1), a surrogate virus of human noroviruses, with STE at 10 and 20 µg/ml concentrations resulted in the reduction of viral replication by 58.5% and 84.9%, respectively. STE treatment induced the expression of mRNAs for type I and type II interferons in HG23 cells and upregulated the transcription of interferon-β in infected RAW 264.7 cells via increased phosphorylation of interferon regulatory factor 3, a critical transcription regulator for type I interferon production. These results suggest that STE inhibits norovirus replication t...Continue Reading

References

Apr 1, 1997·Journal of Ethnopharmacology·A J Kirby, R J Schmidt
Jan 22, 2002·Journal of Ethnopharmacology·Shuang-Cheng MaSong Fong Lee
Jan 31, 2002·Journal of Clinical Pharmacology·Dennis Fung, Clara B S Lau
Feb 16, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mitsutoshi YoneyamaTakashi Fujita
Mar 8, 2003·Science·Stephanie M KarstHerbert W Virgin
Apr 13, 2004·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A DoyleV Vaillant
May 29, 2004·Trends in Microbiology·Anne M HutsonMary K Estes
Dec 14, 2005·Virology·Du-Ping ZhengStephan S Monroe
May 16, 2006·Journal of Virology·Christiane E WobusHerbert W Virgin
Aug 31, 2006·Current Opinion in Infectious Diseases·Mary K EstesRobert L Atmar
Sep 15, 2007·Journal of Virology·Kyeong-Ok Chang, David W George
Jul 19, 2008·PLoS Pathogens·Stephen A McCartneyMarco Colonna
Mar 20, 2009·Journal of Virology·Harish ChangotraStephanie M Karst
Oct 30, 2009·The New England Journal of Medicine·Roger I GlassMary K Estes
Nov 30, 2012·The New England Journal of Medicine·Karin Bok, Kim Y Green
Mar 22, 2013·The New England Journal of Medicine·Daniel C PayneUmesh D Parashar
Jul 31, 2013·Antiviral Research·Hye-Jeong ChoMoon Jung Song
Dec 18, 2015·Current Opinion in Virology·Alexa N Roth, Stephanie M Karst
Nov 27, 2016·Trends in Molecular Medicine·Megan T BaldridgeChristiane E Wobus
Jul 13, 2017·Journal of Food Protection·Ye Won KimSung-Joon Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.